Physician Wealth Advisors’s Cartesian Therapeutics RNAC Stock Holding History

Physician Wealth Advisors’s Portfolio RNAC Stock Details RNAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-144	Closed	-$886	–	2435
2026 Q1	$886	Buy	+144	New	+$1.03K	﹤0.01%	1750

Other funds holding RNAC

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Physician Wealth Advisors's RNAC Position: Q2 2026 in Review

Physician Wealth Advisors sold out of Cartesian Therapeutics (RNAC) in Q2 2026, closing a stake of 144 shares — an estimated $886 sold.

Physician Wealth Advisors first reported a position in RNAC in Q1 2026 and held it in 1 quarter. The position peaked at $886 in Q1 2026. 5 funds tracked by Wall St. Rank hold RNAC as of Q2 2026.

Physician Wealth Advisors reported no remaining Cartesian Therapeutics position as of Q2 2026 after selling out during the quarter.
Physician Wealth Advisors sold 144 Cartesian Therapeutics shares in Q2 2026, an estimated $886.
Physician Wealth Advisors first reported a position in Cartesian Therapeutics in Q1 2026 and held it in 1 quarter.
Physician Wealth Advisors's Cartesian Therapeutics position peaked at $886 in Q1 2026.
5 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.